Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm(TM) Electronic Data Capture Solution
WALTHAM, Mass.----Nov. 5, 2009-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development services for a broad range of pharmaceutical and biotech customers.
more
Scientists Launch Effort to Sequence the DNA of 10,000 Vertebrates
November 05, 2009 -- Scientists have an ambitious new strategy for untangling the evolutionary history of humans and their biological relatives: a genetic menagerie made of the DNA of more than 10,000 vertebrate species. The plan, proposed by an international consortium of scientists, is to obtain, preserve, and sequence the DNA of approximately one species for each genus of living mammals, birds, reptiles, amphibians, and fish.
more
Phase Forward Announces Share Repurchase Program
WALTHAM, Mass.--Nov. 4, 2009-- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that its board of directors has authorized the repurchase of up to $40.0 million of its common stock over the next twelve months. Under the program Phase Forward may repurchase shares from time to time at prevailing prices in the open market or in negotiated transactions off the market. The Company expects to use cash on...
more
All rights reserved. Terms and Conditions | Contact us
